Related Article from Making Sense of Missense in Lynch Syndrome: The Clinical Perspective

Related Article from Making Sense of Missense in Lynch Syndrome: The Clinical Perspectiv

Supplementary Table and Figures from Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer

Supplementary Table 1: Clinicopathological features of patients according to XPO5 expression (original validation cohort-2) Supplementary Table 2: Multivariate analysis for the predictors of disease-free survival in patients with colorectal cancer (original validation cohort-2) Supplementary Fig. 1: XPO5 expression analysis in discovery cohort. Supplementary Fig. 2: Clinicopathological significance of XPO5 expression in CRC patients Supplementary Fig. 3: The relationship between microsatellite status and XPO5 expression Supplementary Fig. 4: Intracellular localization of XPO5 Supplementary Fig. 5: pri-miRNA expression in siXPO5 CRC cells</p

Supplementary Table 1 from Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening

Supplementary Table 1 from Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screenin

Supplementary Figure-6 from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary Figure-6. The effects of miR-34a over-expression on cell function colorectal cancer cells.</p

Supplementary tables and Figure Legends from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary tables and Figure Legends</p

Supplementary Figure-7 from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary Figure-7. The effects of miR-27a knockdown on cell function in colorectal cancer cells.</p

Supplementary Figure-4 from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary Figure-4. The effects of curcumin and AKBA on miR-34a, miR-27a, miR-16 and miR-145 expression in CRC cell lines.</p

Supplementary Figure-1 from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary Figure-1. Inhibitory concentration 50 of curcumin and AKBA.</p

Supplementary Figure-5 from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary Figure-5. Curcumin and AKBA modulate genes involved in cell cycle regulation.</p

Supplementary Figure-3 from Novel Evidence for Curcumin and Boswellic Acid–Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer

Supplementary Figure-3. Curcumin and AKBA inhibit cellular proliferation in 3D cultures.</p